B. G. Susan Robinson

Nessuna posizione attualmente

62 anni

Health Technology

Consumer Services

Profilo

B.
G.
Susan Robinson has been President and Chief Executive Officer of Targeted Genetics Corp.
since November 6, 2008 and a Director since November 14, 2008.
Prior to Targeted Genetics, she was Director-Business Development of Genzyme Molecular Oncology.
Ms. Robinson held various positions for Immulogic Pharmaceuticals Corporation and T-Cell Sciences, Inc. She received a degree from Yale University.

Precedenti posizioni note di B. G. Susan Robinson

Società	Posizione	Fine
AmpliPhi Biosciences Corp. AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.	Presidente	-

Vedi nel dettaglio l'esperienza di B. G. Susan Robinson

Formazione di B. G. Susan Robinson

Yale University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di B. G. Susan Robinson

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
AmpliPhi Biosciences Corp. AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.	Health Technology